Svetlana Nikic, Founder of Precision Oncology Consulting, shared a post on LinkedIn:
“One of my connections, Marina Puchinskaya, an oncologist with a strong interest in understanding the current use of genetic and molecular profiling in clinical practice, has developed a survey exploring clinicians’ experiences, adoption patterns, and potential barriers.
The findings could provide valuable insights for multiple stakeholders across precision oncology, including clinicians, diagnostic companies, technology developers, researchers, and policymakers. They may also help guide the development of educational resources and support programmes that better address healthcare professionals’ needs.
If you are an oncologist, I encourage you to take a few minutes to complete the survey and share your perspective. Your input can help shape future education, implementation strategies, and access to molecular testing.
Other articles featuring Svetlana Nikic on OncoDaily.